Cullinan Oncology Provides Corporate Update and Reports First Quarter 2023 Financial Results
<!-- Name:DistributionId Value:8837776 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Browsing Tag
Cullinan Oncology Inc.
Cullinan Oncology to Present First Clinical Data Evaluating Novel Anti-MICA/B Antibody, CLN-619, in…
<!-- Name:DistributionId Value:8826189 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Cullinan Oncology to Participate in the Guggenheim 5th Annual Oncology Conference and the SVB…
<!-- Name:DistributionId Value:8742071 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…